1. Home
  2. RCKT vs HLLY Comparison

RCKT vs HLLY Comparison

Compare RCKT & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • HLLY
  • Stock Information
  • Founded
  • RCKT 1999
  • HLLY 1903
  • Country
  • RCKT United States
  • HLLY United States
  • Employees
  • RCKT N/A
  • HLLY N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • HLLY Auto Parts:O.E.M.
  • Sector
  • RCKT Health Care
  • HLLY Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • HLLY Nasdaq
  • Market Cap
  • RCKT 328.6M
  • HLLY 437.4M
  • IPO Year
  • RCKT N/A
  • HLLY N/A
  • Fundamental
  • Price
  • RCKT $3.28
  • HLLY $4.07
  • Analyst Decision
  • RCKT Buy
  • HLLY Strong Buy
  • Analyst Count
  • RCKT 13
  • HLLY 6
  • Target Price
  • RCKT $12.96
  • HLLY $5.13
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • HLLY 871.4K
  • Earning Date
  • RCKT 08-07-2025
  • HLLY 08-06-2025
  • Dividend Yield
  • RCKT N/A
  • HLLY N/A
  • EPS Growth
  • RCKT N/A
  • HLLY N/A
  • EPS
  • RCKT N/A
  • HLLY N/A
  • Revenue
  • RCKT N/A
  • HLLY $593,797,000.00
  • Revenue This Year
  • RCKT N/A
  • HLLY $0.19
  • Revenue Next Year
  • RCKT $108.43
  • HLLY $5.09
  • P/E Ratio
  • RCKT N/A
  • HLLY N/A
  • Revenue Growth
  • RCKT N/A
  • HLLY N/A
  • 52 Week Low
  • RCKT $2.19
  • HLLY $1.60
  • 52 Week High
  • RCKT $22.01
  • HLLY $4.10
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • HLLY 79.82
  • Support Level
  • RCKT $2.88
  • HLLY $3.58
  • Resistance Level
  • RCKT $3.74
  • HLLY $3.91
  • Average True Range (ATR)
  • RCKT 0.27
  • HLLY 0.16
  • MACD
  • RCKT 0.02
  • HLLY 0.03
  • Stochastic Oscillator
  • RCKT 35.43
  • HLLY 96.32

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About HLLY Holley Inc.

Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.

Share on Social Networks: